IONS — IONIS PHARMACEUTICALS INC
As of Q2 2026, 42 SEC-registered investment managers reported holding IONS (IONIS PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $3.79B across 111.99M shares. That is -45.8% by share count (-94.56M shares) versus the previous quarter, while reported value moved +12.5%. Ownership is concentrated: the five largest holders account for 74.1% of reported value and the top ten for 86.2%.
Compared with the prior quarter, 1 opened new positions, 17 added to existing stakes, 22 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
IONS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Capital World Investors history | Q2 2026 | 21.67M | $1.72B | 0.21% | Add |
| Vanguard Group history | Q4 2025 | 16.44M | $1.30B | 0.02% | Hold |
| Two Sigma Investments history | Q2 2026 | 6.25M | $495.75M | 0.38% | Add |
| Geode Capital Management history | Q2 2026 | 3.58M | $294.75M | 0.02% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 2.11M | $167.30M | 0.01% | Reduce |
| Franklin Resources history | Q2 2026 | 1.62M | $128.72M | 0.03% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.61M | $127.26M | 0.02% | Add |
| Morgan Stanley history | Q2 2026 | 1.28M | $101.61M | 0.01% | Add |
| Invesco Ltd history | Q2 2026 | 1.12M | $88.86M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 913.61K | $72.44M | 0.01% | Add |
| Citadel Advisors history | Q2 2026 | 855.28K | $67.82M | 0.01% | Reduce |
| Bank of America Corp history | Q2 2026 | 790.99K | $62.72M | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 651.82K | $51.68M | 0.02% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 632.03K | $50.11M | 0.02% | Reduce |
| Renaissance Technologies history | Q2 2026 | 559.41K | $44.36M | 0.06% | Add |
| Millennium Management history | Q2 2026 | 546.37K | $43.32M | 0.02% | Reduce |
| BNY Mellon history | Q2 2026 | 542.45K | $43.01M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 384.54K | $30.49M | 0.02% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 17.50M | $27.22M | 0.04% | Reduce |
| Capital Research Global Investors history | Q2 2026 | 331.94K | $26.32M | 0.00% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 553.00K sh · $872.94K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 68.19K sh · $5.12M
- Principal Global Investors sold 7.02K sh · $527.06K
- Farallon Capital Management sold 4.80K sh · $360.43K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital World Investors | — | — | — | — | — | — | — | 839.46K | 839.46K | 839.46K | 839.46K | 2.25M | 7.83M | 11.47M | 12.36M | 12.54M | 12.72M | 17.96M | 21.19M | 21.67M |
| Two Sigma Investments | 314.13K | 594.88K | 780.26K | 560.03K | 292.99K | 201.27K | 23.08K | 213.37K | 476.06K | 801.45K | 1.08M | 1.03M | 919.08K | 921.44K | 1.69M | 1.79M | 1.58M | 20.00M | 5.86M | 6.25M |
| Geode Capital Management | 1.77M | 1.83M | 1.90M | 1.87M | 1.90M | 2.01M | 2.07M | 2.16M | 2.19M | 2.28M | 2.36M | 2.48M | 2.67M | 2.69M | 2.84M | 2.89M | 3.07M | 3.15M | 3.98M | 3.58M |
| Goldman Sachs Group | 601.84K | 589.30K | 954.33K | 1.04M | 1.29M | 947.41K | 422.10K | 188.37K | 346.73K | 441.38K | 224.38K | 371.81K | 335.71K | 478.21K | 652.52K | 777.94K | 810.00K | 2.00M | 2.46M | 2.11M |
| Franklin Resources | — | — | — | — | 11.25K | 13.72K | 10.40K | 9.17K | 8.45K | 13.71K | 9.81K | 10.02K | 10.15K | 13.30K | — | 5.56K | 6.59K | 1.32M | 1.58M | 1.62M |
| Charles Schwab Investment Management | 1.07M | 1.09M | 1.14M | 1.15M | 1.20M | 1.26M | 1.19M | 1.20M | 1.24M | 1.28M | 1.30M | 1.33M | 1.44M | 1.48M | 1.44M | 1.49M | 1.52M | 1.54M | 1.58M | 1.61M |
| Morgan Stanley | 384.00K | 20.00K | 20.00K | 3.72M | 1.55M | 5.40M | 5.72M | 6.58M | 7.09M | 6.74M | 6.74M | 31.00K | 1.30M | 1.07M | 17.66M | 15.03M | 12.78M | 80.00K | 94.00K | 1.28M |
| Invesco Ltd | 141.35K | 132.24K | 139.99K | 261.00K | 261.00K | 261.00K | 261.00K | 261.00K | 261.00K | 261.00K | 2.91M | 1.65M | 1.50M | 1.50M | 1.50M | 256.24K | 519.07K | 1.50M | 1.28M | 1.12M |
| Northern Trust Corp | 655.42K | 660.89K | 648.53K | 625.47K | 623.64K | 639.69K | 658.47K | 671.08K | 690.72K | 687.99K | 692.25K | 717.98K | 742.90K | 840.27K | 834.85K | 814.25K | 844.94K | 846.72K | 868.18K | 913.61K |
| Citadel Advisors | 1.17M | 1.34M | 1.31M | 551.34K | 15.06M | 454.05K | 197.52K | 790.28K | 2.00M | 318.73K | 253.83K | 12.22M | 497.65K | 2.26M | 3.62M | 1.64M | 2.59M | 2.31M | 58.00M | 855.28K |
| Bank of America Corp | 710.12K | 612.84K | 797.16K | 61.00K | 165.00K | 6.75M | 632.64K | 459.32K | 536.04K | 455.08K | 618.10K | 514.54K | 4.83M | 1.54M | 1.82M | 1.41M | 2.27M | 6.76M | 980.00K | 790.99K |
| MFS Investment Management | — | — | — | — | — | — | 27.15K | 26.53K | 5.77K | 5.59K | 5.58K | — | — | — | — | 519.18K | 862.59K | 812.75K | 666.12K | 651.82K |
| Arrowstreet Capital | 41.10K | — | — | 41.10K | — | — | — | — | — | — | — | — | — | — | — | — | 630.14K | 1.06M | 737.86K | 632.03K |
| Renaissance Technologies | 97.71K | 230.81K | 134.91K | 614.81K | 867.71K | 1.18M | 636.31K | 370.50K | 269.80K | 112.41K | 179.71K | 249.51K | 190.51K | 205.51K | 153.51K | 270.71K | 486.71K | 223.61K | 305.55K | 559.41K |
| Millennium Management | 282.85K | 1.62M | 191.19K | 320.62K | 18.93K | 115.51K | 45.36K | 418.91K | 437.12K | 890.33K | 583.18K | 128.22K | 430.72K | 774.22K | 635.37K | 2.65M | 779.57K | 93.26K | 1.05M | 546.37K |
| BNY Mellon | 1.06M | 1.06M | 1.05M | 965.32K | 879.41K | 600.00K | 866.10K | 857.75K | 1.43M | 1.44M | 1.38M | 847.48K | 860.89K | 916.07K | 844.63K | 727.19K | 832.11K | 753.89K | 514.62K | 542.45K |
| D. E. Shaw & Co | 126.11K | 160.66K | 45.48M | 126.62K | 209.44K | 299.23K | 86.65K | 196.21K | 362.05K | 119.16K | 160.48K | 190.78K | 145.09K | 23.12K | 28.00M | 28.00M | 25.50M | 332.80K | 429.60K | 384.54K |
| Balyasny Asset Management | 15.00M | 455.62K | — | 155.53K | — | — | 203.47K | 125.85K | — | — | — | 1.08M | — | — | 260.00K | 1.03M | 1.02M | 381.18K | 35.00M | 17.50M |
| Capital Research Global Investors | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 323.01K | 331.94K |
| ARK Invest | 8.51M | 7.08M | 6.17M | 4.70M | 3.71M | 2.67M | 2.64M | 2.42M | 2.37M | 1.91M | 1.40M | 1.36M | 1.38M | 1.03M | 1.00M | 900.32K | 631.22K | 422.97K | 288.72K | 300.77K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details